Drugs similar to or like CVnCoV
COVID-19 vaccine candidate developed by CureVac AG and the Coalition for Epidemic Preparedness Innovations . Wikipedia
Global initiative aimed at equitable access to COVID-19 vaccines led by the Global Alliance for Vaccines and Immunization , the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and others. One of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the World Health Organization , the European Commission, and the government of France as a response to the COVID-19 pandemic. Wikipedia
Foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID). Focused on the World Health Organization's "blueprint priority diseases", which include: the Middle East respiratory syndrome-related coronavirus (MERS-CoV), the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen "Disease X". Wikipedia
COVID-19 vaccine developed by the United States National Institute of Allergy and Infectious Diseases , the Biomedical Advanced Research and Development Authority (BARDA), and Moderna. Administered by two 0.5 mL doses given by intramuscular injection given four weeks apart. Wikipedia
COVID-19 vaccine developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Followed by a full-dose after at least one month, based on mixed trials with no participants over 55 years old. Wikipedia
Inactivated virus based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and provided the virus strains for developing a fully indigenous COVID-19 vaccine. Wikipedia
Isolated in December 2019, its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since early 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. Wikipedia
As of 19 February 2021, 200.33 million COVID‑19 vaccine doses had been administered worldwide based on official reports from national health agencies collated by Our World in Data. During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating the distribution of the eventual vaccine(s). Wikipedia
Part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Confirmed to have spread to Belgium on 4 February 2020, when one of a group of nine Belgians repatriated from Wuhan to Brussels was reported to have tested positive for the coronavirus. Wikipedia
- , the CVnCoV RNA vaccine from CureVac is awaiting authorization in the EU.
- A third mRNA-based COVID-19 vaccine, CVnCoV, is in late-stage testing.
- In February 2021, the CHMP started a rolling review of NVX-CoV2373, a COVID‑19 vaccine being developed by Novavax CZ AS (a subsidiary of Novavax, Inc.) and a rolling review of CVnCoV, a COVID‑19 vaccine being developed by CureVac AG.
This will create an email alert. Stay up to date on result for: CVnCoV